[Organ-specific in vivo dipeptide (alanylglutamine, glycylglutamine) values in catabolic dogs].
Karner
J
J
I. Chirurgische Univ.-Klinik Wien, Osterreich.
Roth
E
E
Karner-Hanusch
J
J
Kovats
E
E
Fürst
P
P
Funovics
J
J
Fritsch
A
A
D000818:Animals; D004151:Dipeptides / Q000008:administration & dosage / Q000493:pharmacokinetics*; D004195:Disease Models, Animal; D004285:Dogs; D007275:Injections, Intravenous; D007700:Kinetics; D014018:Tissue Distribution; D014947:Wounds and Injuries / Q000378:metabolism
D004151:Dipeptides; C039788:glycylglutamine; C054122:alanylglutamine
Organspezifische In-vivo-Dipeptidverwertung (Alanyl-Glutamin, Glyzyl-Glutamin) beim katabolen Hund.